Connexin 43-Enhanced Suicide Gene Therapy Using Herpesviral Vectors

Molecular Therapy

Volumn 1, Issue 1, 2000, Pages 71-81

  Marconi, Peggy ^a   Tamura, Masakazu ^a   Moriuchi, Shusuke ^a   Krisky, David M ^a   Niranjan, Ajay ^a   Goins, William F ^a   Cohen, Justus B ^a   Glorioso, Joseph C ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Bystander effect; thymidine kinase; connexin; HSV vector; gene therapy

Indexed keywords

ANTIVIRUS AGENT; CONNEXIN 43; GANCICLOVIR; THYMIDINE KINASE;

ANIMAL; ARTICLE; BRAIN TUMOR; CANCER TRANSPLANTATION; CELL CULTURE; COMPARATIVE STUDY; EXPERIMENTAL NEOPLASM; FEMALE; FIBROSARCOMA; GENE EXPRESSION; GENE THERAPY; GENE VECTOR; GENETICS; GLIOBLASTOMA; HERPES SIMPLEX VIRUS 1; HUMAN; METHODOLOGY; MOUSE; MULTIMODALITY CANCER THERAPY; NUDE MOUSE; XENOGRAFT;

ANIMALS; ANTIVIRAL AGENTS; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; CONNEXIN 43; FEMALE; FIBROSARCOMA; GANCICLOVIR; GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; GLIOBLASTOMA; HERPESVIRUS 1, HUMAN; HUMANS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; THYMIDINE KINASE; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0033651048     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1006/mthe.1999.0008     Document Type: Article

References (60)

1. Akkaraju G. R., Huard J., Hoffman E. P., Goins W. F., Pruchnic R., Watkins S. C., Cohen J. B., Glorioso J. C. Herpes simplex virus vector-mediated dystrophin gene transfer and expression in MDX mouse skeletal muscle. J. Gene Med. 1:1999;280-289.
2. Andreansky S., He B., van Cott J., McGhee J., Markert J. M., Gillespie G. Y., Roizman B., Whitley R. J. Treatment of intracranial gliomas in immunocompetent mice using herpes simplex viruses that express murine interleukins. Gene Ther. 5:1998;121-130.
3. Barba D., Hardin J., Ray J., Gage F. H. Thymidine kinase-mediated killing of rat brain tumors. J. Neurosurg. 79:1993;729-735.
4. Barba D., Hardin J., Sadelain M., Gage F. H. Development of antitumor immunity for following thymidine kinase-mediated killing of experimental brain tumors. Proc. Natl. Acad. Sci. USA. 91:1994;4348-4352.
5. Benedetti S., Dimeco F., Pollo B., Cirenei N., Colombo B., Bruzzone M., Cattaneo E., Vescovi A., Didonato S., Colombo M., Finocchiaro G. Limited efficacy of the HSV-TK/GCV system for gene therapy of malignant gliomas and perspectives for the combined transduction of the interleukin-4 gene. Hum. Gene Ther. 20:1997;1345-1353.
6. Bi W. L., Parysek L. M., Warnick R., Stambrook P. J. In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HCV Tk retroviral gene therapy. Hum. Gene. Ther. 4:1993;725-731.
7. Boviatsis E. J., Park J. S., Sena-Esteves M., Kramm C. M., Chase M., Efird J. T., Wei M. X., Breakefield X. O., Chiocca E. A. Long-term survival of rats harboring brain neoplasms treated with ganciclovir and a herpes simplex virus vector that retains an intact thymidine kinase gene. Cancer Res. 15:1994;5745-5751.
8. Burger P., Scheithauer B. Tumors of the central nervous system. Atlas of Tumor Pathology. 1994;Armed Forces Institute of Pathology, Washington. p. 59.
9. Caruso M., Panis Y., Gagandeep S., Houssin D., Salzmann J. L., Klatzmann D. Regression of established macroscopic liver metastases after in situ transduction of a suicide gene. Proc. Natl. Acad. Sci. USA. 90:1993;7024-7028.
10. Chen S. H., Shine H. D., Goodman J. C., Grossman R. G., Woo S. L. Gene therapy for brain tumors: Regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc. Natl. Acad. Sci. USA. 91:1994;3054-3057.
11. Cirenei N., Colombo B. M., Mesnil M., Benedetti B., Yamasaki H., Finocchiaro G. In vitro and in vivo effects of retrovirus-mediated transfer of the connexin 43 gene in malignant gliomas: Consequences for HSVtk/GCV anticancer gene therapy. Gene Ther. 5:1998;1221-1226.
12. Colombo B. M., Benedetti S., Ottolenghi S., Mora M., Pollo B., Poli G., Finocchiaro G. The "bystander effect": Association of U-87 cell death with ganciclovir-mediated apoptosis of nearby cells and lack of effect in athymic mice. Hum. Gene Ther. 6:1995;763-772.
13. Culver K., Ram Z., Walbridge S., Ishii H., Oldfield E., Blaese R. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science. 256:1992;1550-1552.
14. Daikoku T., Yamashita Y., Tsurumi T., Maeno K., Nishiyama Y. Purification and biochemical characterization of the protein kinase encoded by the US3 gene of herpes simplex virus type 2. Virology. 197:1993;685-694.
15. Danthinne X., Aoki K., Kurachi A., Nabel G., Nabel E. Combination gene delivery of the cell cycle inhibitor p27 with thymidine kinase enhances prodrug cytotoxicity. J. Virol. 72:1998;9201-9207.
16. DeLuca N. A., McCarthy A. M., Schaffer P. A. Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4. J. Virol. 56:1985;558-570.
17. DeLuca N. A., Schaffer P. A. Activation of immediate-early, early, and late promoters by temperature-sensitive and wild-type forms of herpes simplex virus type 1 protein ICP4. Mol. Cell. Biol. 5:1985;1997-2008.
18. Dilber M. S., Abedi M. R., Christensson B., Bjorkstrand B., Kidder G. M., Naus C. C., Gahrton G., Smith C. I. Gap junctions promote the bystander effect of herpes simplex virus thymidine kinase in vivo. Cancer Res. 57:1997;1523-1528.
19. Duflot-Dancer A., Mesnil M., Yamasaki H. Dominant-negative abrogation of connexin-mediated cell growth control by mutant connexin genes. Oncogene. 15:1997;2151-2158.
20. Elshami A. A., Saavedra A., Zhang H., Kucharczuk J. C., Spray D. C., Fishman G. I., Amin K. M., Kaiser L. R., Albelda S. M. Gap junctions play a role in the 'bystander effect' of the herpes simplex virus thymidine kinase/ganciclovir system in vitro. Gene Ther. 3:1996;85-92.
21. Ezzeddine Z. D., Martuza R. L., Platika D., Short M. P., Malick A., Choi B., Breakefield X. O. Selective killing of glioma cells in culture and in vivo by retrovirus transfer of the herpes simplex virus thymidine kinase gene. New Biol. 3:1991;608-614.
22. Fink D., DeLuca N., Goins W., Glorioso J. Gene transfer to neurons using herpes simplex virus-based vectors. Annu. Rev. Neurosci. 19:1996;265-287.
23. Freeman S. M., Abboud C. N., Whartenby K. A., Packman C. H., Koeplin D. S., Moolten F. L., Abraham G. N. The "bystander effect": Tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res. 53:1993;5274-5283.
24. Ghoumari A. M., Rixe O., Yarovoi S. V., Zerrouqi A., Mouawad R., Poynard T., Opolon P., Khayat D., Soubrane C. Gene transfer in hepatocarcinoma cell lines: In vitro optimization of a virus-free system. Gene Ther. 3:1996;483-490.
25. Glorioso J., Goins W., Meaney C., Fink D., DeLuca N. Gene transfer to brain using herpes simplex virus vectors. Ann. Neurol. 35:1994;S28-S34.
26. Glorioso J. C., Robbins P. D., Krisky D., Marconi P., Goins W. F., Schmidt M. C., Evans C. H. Progress in the development of herpes simplex virus gene vectors for treatment of rheumatoid arthritis. Davidson B. Advanced Drug Delivery Reviews. 1997;41-57.
27. Ishii H. Mechanism of "bystander effect" killing in the herpes simplex thymidine kinase into glioma cells targeting of gancyclovir cytotoxic effect. Neurol. Med. Chir. (Tokyo). 34:1994;1094-1102.
28. Kato K., Yoshida J., Mizuno M., Sugita K., Emi N. Retroviral transfer of herpes simplex thymidine kinase into glioma cells targeting of gancyclovir cytotoxic effect. Neurol. Med. Chir. (Tokyo). 34:1994;339-344.
29. Krisky D. M., Marconi P. C., Oligino T., Rouse R. J. D., Fink D. J., Glorioso J. C. Rapid method for construction of recombinant HSV gene transfer vectors. Gene Ther. 4:1997;1120-1125.
30. Krisky D. M., Marconi P. C., Oligino T. J., Rouse R. J. D., Fink D. J., Cohen J. B., Watkins S. C., Glorioso J. C. Development of herpes simplex virus replication defective multigene vectors for combination gene therapy applications. Gene Ther. 5:1998;1517-1530.
31. Krisky D. M., Wolfe D., Goins W. F., Marconi P. C., Ramakrishnan R., Mata M., Rouse R. J. D., Fink D. J., Glorioso J. C. Deletion of multiple immediate early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons. Gene Ther. 5:1998;1593-1603.
32. Kwong Y., Chen S., Kosai K., Finegold M., Woo S. Combination therapy with suicide and cytokine genes for hepatic metastases of lung cancer. Chest. 112:1997;1332-1337.
33. Marconi P., Krisky D., Oligino T., Poliani P. L., Ramakrishnan R., Goins W. F., Fink D. J., Glorioso J. C. Replication-defective HSV vectors for gene transfer in vivo. Proc. Natl. Acad. Sci. USA. 93:1996;11319-11320.
34. Mehta P. P., Bertram J. S., Loewenstein W. R. Growth inhibition of transformed cells correlates with their junctional communication with normal cells. Cell. 44:1986;187-196.
35. Mesnil M., Piccoli C., Tiraby G., Willecke K., Yamasaki H. Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins. Proc. Natl. Acad. Sci. USA. 93:1996;1831-1835.
36. Mesnil M., Piccoli C., Yamasaki H. A tumor suppressor gene, Cx26, also mediates the bystander effect in HeLa cells. Cancer Res. 57:1997;2929-2932.
37. Moolten F. L. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: Paradigm for a prospective cancer control strategy. Cancer Res. 46:1986;5276-5281.
38. Moriuchi S., Oligino T., Krisky D., Marconi P., Fink D., Cohen J., Glorioso J. C. Enhanced tumor-cell killing in the presence of ganciclovir by HSV-1 vector-directed co-expression of human TNF-a and HSV thymidine kinase. Cancer Res. 58:1998;5731-5737.
39. Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65:1983;55-63.
40. Naus C., Elisevich K., Zhu D., Belliveau D., Del Maestro R. In vivo growth of C6 glioma cells transfected with connexin43 cDNA. Cancer Res. 52:1992;4208-4213.
41. Naus C. C., Bechberger J. F., Paul D. L. Gap junction gene expression in human seizure disorder. Exp. Neurol. 111:1991;198-203.
42. Naus C. C., Bechberger J. F., Zhang Y., Venance L., Yamasaki H., Juneja S. C., Kidder G. M., Giaume C. Altered gap junctional communication, intercellular signaling, and growth in cultured astrocytes deficient in connexin43. J. Neurosci. Res. 49:1997;528-540.
43. O'Malley B., Cope K., Chen S., Li D., Schwarta M., Woo S. Combination gene therapy for oral cancer in a murine model. Cancer Res. 56:1996;1737-1741.
44. Okada H., Giezeman-Smits K., Tahara H., Attanucci J., Fellows W., Lotze M., Chambers W., Bozik M. Effective cytokine gene therapy against an intracranial glioma using a retrovirally transduced IL-4 plus HSVtk tumor vaccine. Gene Ther. 6:1999;219-226.
45. Palu G., Cavaggioni A., Calvi P., Franchin E., Pizzato M., Boschetto R., Parolin C., Chilosi M., Ferrini S., Zanusso A., Colombo F. Gene therapy of glioblastoma multiforme via combined expression of suicide and cytokine genes: A pilot study in humans. Gene Ther. 6:1999;330-337.
46. Perez-Cruet M., Trask T. W., Chen S. H., Goodman J. C., Woo S. L., Grossman R. G., Shine H. D. Adenovirus-mediated gene therapy of experimental gliomas. J. Neurosci. Res. 39:1994;506-511.
47. Ram Z., Culver K. W., Walbridge S., Blaese R. M., Oldfield E. H. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Cancer Res. 46:1986;5276-5281.
48. Ram Z., Wallbridge S., Shawker T., Culver K. W., Blaese R. M., Oldfield E. H. The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculature and growth of 9L gliomas in rats. J. Neurosurg. 81:1994;256-260.
49. Ramesh R., Marrogi A., Munshi A., Abboud C., Freeman S. M. In vivo analysis of the 'bystander effect': A cytokine cascade. Exp. Hematol. 24:1996;829-838.
50. Rasty S., Poliani P., Fink D., Glorioso J. Deletion of the S component inverted repeat sequence c′ and the nonessential genes Us1 through Us5 from the herpes simplex virus type 1 genome substantially impairs productive viral infection in cell culture and pathogenesis in the rat central nervous system. J. Neurovirol. 3:1997;247-264.
51. Samaniego L., Wu N., DeLuca N. A. The herpes simplex virus immediate-early protein ICP0 affects transcription from the viral genome and infected-cell survival in the absence of ICP4 and ICP27. J. Virol. 71:1997;4614-4625.
52. Samaniego L. A., Neiderhiser L., DeLuca N. A. Persistence and expression of the herpes simplex virus genome in the absence of immediate-early proteins. J. Virol. 72:1998;3307-3320.
53. Shinoura N., Chen L., Wani M. A., Kim Y. G., Larson J. J., Warnick R. E., Simon M., Menon A. G., Bi W. L., Stambrook P. J. Protein and messenger RNA expression of connexin43 in astrocytomas: Implications in brain tumor gene therapy. J. Neurosurg. 84:1996;839-845.
54. Short M. P., Choi B. C., Lee J. K., Malick A., Breakefield X. O., Martuza R. L. Gene delivery to glioma cells in rat brain by grafting of a retrovirus packaging cell line. J. Neurosci. Res. 27:1990;427-439.
55. Touraine R. L., Vahanian N., Ramsey W. J., Blaese R. M. Enhancement of the herpes simplex virus thymidine kinase/ganciclovir bystander effect and its antitumor efficacy in vivo by pharmacologic manipulation of gap junctions. Hum. Gene Ther. 9:1998;2385-2391.
56. Vrionis F. D., Wu J. K., Qi P., Waltzman M., Cherington V., Spray D. C. The bystander effect exerted by tumor cells expressing the herpes simplex virus thymidine kinase (HSVtk) gene is dependent on connexin expression and cell communication via gap junctions. Gene Ther. 4:1997;577-585.
57. Wu J. K., Cano W. G., Meylaerts S. A., Qi P., Vrionis F., Cherington V. Bystander tumoricidal effect in the treatment of experimental brain tumors. Neurosurgery. 35:1994;1094-1102.
58. Wu N., Watkins S. C., Schaffer P. A., DeLuca N. A. Prolonged gene expression and cell survival after infection by a herpes simplex virus mutant defective in the immediate-early genes encoding ICP4, ICP27, and ICP22. J. Virol. 70:1996;6358-6368.
59. Yamasaki H. Role of disrupted gap junctional intercellular communication in detection and characterization of carcinogens. Mutat. Res. 365:1996;91-105.
60. Zhu D., Caveney S., Kidder G. M., Naus C. C. Transfection of C6 glioma cells with connexin 43 cDNA: Analysis of expression, intercellular coupling, and cell proliferation. Proc. Natl. Acad. Sci. USA. 88:1991;1883-1887.